Kamada BioPharma Limited

Company snapshot

Kamada BioPharma Limited is a biotech organization headquartered in GB. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Kamada BioPharma Limited. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Kamada BioPharma Limited.

1. Jun 8, 2026 Clinical update

   KamadaAATInhaled008 — Phase 3

View all clinical trial activity →

• What is Kamada BioPharma Limited?

  Kamada BioPharma Limited is a biotech organization headquartered in GB. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (1).

• Is Kamada BioPharma Limited publicly traded?

  Kamada BioPharma Limited appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Kamada BioPharma Limited develop or market?

  We link 3 drug profile(s) where Kamada BioPharma Limited is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/kamada-biopharma-limited-at-fieldfisher-llp#company-drugs.

• What are the latest developments for Kamada BioPharma Limited?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Kamada BioPharma Limited focus on?

  No specific therapeutic focus areas are currently identified for Kamada BioPharma Limited in our database.